glutathione and triple negative breast cancer Dual metabolic targeting liposomes potentiate triple-negative radiosensitivity via glucose starvation Frontiers | Ferroptosis: the emerging
Frontiers Ferroptosis: the emerging player in remodeling triple negative breast cancer Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect The Potential of Hormonal Therapies for Treatment of Triple Negative Breast Cancer Comprehensive single cell metabolic profiling identifies targets to sensitize triple negative breast cancer to chemo immunotherapy: Cell Reports Medicine Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect
Pay in 4 interest-free payments of $6.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




